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Homeopathy is a frequently used complementary and alternative medicine (CAM) treatment. We present results comparing
responses of homeopathy users (HUs) and users of other forms of CAM (NHUs) in pediatric oncology (PO) in Germany.
Diﬀerences between these two groups (usage, associated demographic characteristics, previous experience with CAM) are
investigated. 186 (45.2%) of the 367 CAM users were exposed to homeopathy. The treatment duration amounted to a median
of 601 days for HUs and 282 days for NHUs. Parents with p (127; 76.5%) also used homeopathy for their child’s cancer.
Nonmedical practitioners played a considerably greater role as source of information than did treating physician. In the majority
HUs received their prescriptions from nonmedical practitioners (56%; 29.4% of NHUs). HUs communicate more frequently with
their physicians about the CAM-use (77.7% versus 65.2%) and recommend CAM more often than NHUs (94% versus 85.6%).
Homeopathy is the most frequently used CAM treatment in PO in Germany. HUs sustain treatment and therapies considerably
longer than NHUs. Most families who had used homeopathy before their child was diagnosed with cancer also used homeopathy
for the treatment of their child’s cancer. Compared to other CAM treatments, patient satisfaction with homeopathy appears to be
very high.
1.Introduction
Complementary and alternative therapies (CAM) are fre-
quently used in the treatment of acute and chronic disease
both in Germany and worldwide. This applies equally to
adults [1–3] and children [1–4]. Published data on the
frequency of CAM used speciﬁcally in pediatric oncology
is available in the form of usually smaller single-centre
studies [5–14]. A parent survey on use of CAM in pediatric
oncology published by us involved 1595 parents and is both
the most extensive and the only population-based study of
this kind in the international literature to date. This survey
showed that CAM was used by 35% of the 1063 patients
whose parents participated in the study [15]. An exploratory
multiple analysis showed that the following factors had a
signiﬁcant inﬂuence on the probability of CAM use (in
order of importance): earlier experience of CAM (OR =
4.72, P<. 0001), diagnosis with poor prognosis (OR =
1.63, P = .0013), child died before the survey (OR = 1.97,
P = .0063), and higher social status (OR = 1.44, P =
.1264). Despite the dispute concerning homoeopathy [16],
weassumeagrowingnumberofpatientsusinghomoeopathy
in pediatric oncology. Therefore, it is of interest to examine
the use of homoeopathy and user proﬁles among children
with oncological malignancies in Germany.
No studies on the use of homeopathy in pediatric oncol-
ogy have been published to date. With the exception of a few
supportiveindications,homeopathicmedicationinpediatric
oncology is used as an adjunct to conventional medicine.
Homoeopathy is a well-known system of medicine that
follows the “principle of similar” which treats “like with like”
with potentized substances at a dilution level far beyond the
Avogadro number. The majority of homoeopathic remedies
are made from natural substances (e.g., plants, minerals, or2 Evidence-Based Complementary and Alternative Medicine
animals). Two large and methodologically sophisticated epi-
demiological studies on the use of homeopathy in children
in Germany were recently published [17, 18]. Homeopathy is
prescribed both by doctors and by nonmedical practitioners
(“Heilpraktiker,” naturopaths, chiropractors, etc.) and also
used as self-medication [19, 20]. The publications on the
use of CAM in pediatric oncology show consistently that
homeopathy plays a signiﬁcant role in many developed
countries as well as in other countries such as India, for
example.
In this retrospective, representative, and population-
based parent survey, we compared the group of homeopathy
users (Hus) with the users of other CAM therapies (NHUs)
to establish whether there are any diﬀerences between
these two groups with regard to patterns of CAM-use, the
attending circumstances, or previous experience of CAM.
2. Patientsand Methods
The postal survey sent to parents was carried out in
2004 in collaboration with the Deutsche Kinderkrebsregister
(GCCR) (German Childhood Cancer Registry). The study
population included all parents in Germany with a child
(under the age of 15 years) diagnosed in 2001 with one of the
diseases registered and systematically recorded by the GCCR.
At least 95% of all German cases of childhood cancer are
registered in the GCCR. Exclusion criteria were death within
the ﬁrst 8 weeks after diagnosis and development of a second
cancer. The survey was conducted in coordination with all
German hospitals that had treated children with leukemia
and cancer in the year 2001 and had reported to the GCCR.
The hospitals were permitted to exclude individual patients
from the survey (stating reasons if possible). The selected
families were sent the questionnaire by mail. The list of
alternative and complementary treatment methods given in
the questionnaire was as comprehensive as possible in order
to obtain as realistic as possible a picture of the diﬀerent
methods used. The systematically developed German lan-
guage questionnaire for parents was based on data published
on this topic to date, our own clinical experience, and the
experience obtained from a pilot survey [21].
Among other things, the questionnaire provided an
alphabetic list of 69 possible CAM treatments and therapies,
of which “homeopathy” was one. Those CAM-users who
named this category were deﬁned as homeopathy users
(Hus) and their data compared with those of the group of
nonhomeopathy users (NHUs) (i.e., users of other forms
of complementary or alternative medicine but not home-
opathy) and examined with respect to patterns of CAM-use,
attending circumstances, and previous experience of CAM.
All patients had received conventional treatment as well
as the speciﬁed complementary treatments or therapies.
Because we had no information from so-called “treatment
refusers,” we are unable to comment on their use of comple-
mentary and alternative therapies. But “treatment refusers”
are extremely rare in Germany. The study was approved by
the ethics committee of the University of Witten/Herdecke,
Germany, and carried out in accordance with the World
Medical Association Declaration of Helsinki [22].
3.StatisticalAnalysis
Thiswasnotananalyticalstudyandthereforeresultsarepre-
sented primarily in the form of descriptive statistics, that is,
percentages relating to the mostly categorical data collected.
The basic percentages are supplemented by binomial 95%
conﬁdence intervals (95% CI) reﬂecting the precision of the
estimate.Themainmeasureisthecomparisonofpercentages
between the groups. Some of the more relevant diﬀerences
between the HU and NHU groups were tested by the χ2-test
for homogeneity in tables. These tests should also be viewed
as exploratory in nature, not conﬁrmatory.
4. Results
4.1. CAM Use. Of the 1063 families who responded, 367
(35%, 95% CI (31.7%; 37.4%)) stated that they had used
CAM in the course of their child’s illness. Of these 367 CAM
users, 166 (45.2%) reported that they had used homeopathic
medicines. This was thus the numerically largest group of
CAM users. When asked for the “most important” CAM
therapies used, 137 (37.3%) of all CAM-users reported that
they had given homeopathic medicines (Table 1).
The mean duration of use of homeopathic medicines
was 601 days. The mean duration of use of all other CAM
therapieswas282days.Thesearelowestestimates,asinmany
cases, treatments were still ongoing at the time of the survey.
An analysis of the frequency of use of diﬀerent CAM-
therapies by diagnostic group on the basis of the diagnostic
groups recorded in the GCCR did not show any particular
concentration of homeopathy users in speciﬁc diagnostic
groups (data not shown). A total of 396 (37.3%) of the
survey participants had previous experience of CAM. This
previous experience was most often with homeopathy (n =
280; multiple responses allowed). Of the 166 homeopathy
users 127 (76.5%) had previous experience of homeopathy.
A further 38 (22.9%) homeopathy users had no previous
CAM experience. In the NHU group (n = 201) on the
otherhand,noneoftherespondentshadpreviousexperience
of homeopathy, 100 (49.8%) had previous experience of
other CAM therapies and 98 (48.8%) had no previous CAM
experience (not speciﬁed 3 (1.5%)) (Table 2). Comparison
of these two groups with regard to their previous experience
of homeopathy shows a highly signiﬁcant diﬀerence (P<
.0001).
There was no diﬀerence between the HU and NHU
groups with regard to either the prognosis of the underlying
disease or the attribute “death of the child before participa-
tion” (data not shown). The percentage of HUs with high
social status was the same as in the group of NHUs (52%
and 47.6%, resp.).
4.2. Attending Circumstances of CAM Use. Comparison
between HUs and NHUs with regard to the reasons for using
CAM showed that the categories “for physical stabilization”
(77.7% versus 63.2%), “to enhance the immune system”
(72.3% versus 61.2%), “to improve the tolerability of the
conventional treatment” (58.4% versus 39.3%), and “for
detoxiﬁcation” (42.2% versus 19.9%) were named noticeablyEvidence-Based Complementary and Alternative Medicine 3
Table 1: The “most important” CAM treatment methods from the users’ viewpoint. Selection: treatment methods listed at least 10 times
(n = 367 CAM-users; multiple answers possible).
CAM treatment methods Number of patients (%)
Homeopathy 137 (37.3)
Mistletoe therapy 53 (14.4)
Anthroposophic-homeopathic medications (except for mistletoe therapy) 46 (12.5)
Food supplements 43 (11.7)
Reiki 27 (7.4)
Dietary changes 26 (7.1)
Laying on of hands 22 (6.0)
Medicines of plant origin (Phytotherapy) 21 (5.7)
Selenium 21 (5.7)
Vitamin C 21 (5.7)
Massage 19 (5.2)
Other 19 (5.2)
Spiritual healer 18 (4.9)
Ayurveda, for example, H15 (incense) 16 (4.4)
High dosage vitamins 16 (4.4)
Bach Flower Remedies 15 (4.1)
Acupuncture 14 (3.8)
Bioresonance 13 (3.5)
Kinesiology 13 (3.5)
Osteopathy 12 (3.3)
“Biochemistry according to Sch¨ ussler” 11 (3.0)
“Energy work” 11 (3.0)
Music therapy 11 (3.0)
... ...
Table 2: Previous experience of CAM in the family before a child was diagnosed with cancer (n = 1063 questionnaire participants).
Previous experience
CAM-users (n = 367)
HU (%) n = 166 NHU (%) n = 201 CAM-nonusers (%)
n = 696
Previous experience with homeopathy 121 (72,9) 55 (27,4) 104 (14,9)
Previous experience with CAM, but no previous
experience with homeopathy 6 (3,6) 45 (22,4) 65 (9,3)
No previous experience of CAM 38 (22,9) 98 (48,8) 517 (74,3)
No answer given 1 (0,6) 3 (1,5) 10 (1,4)
P<. 0001
more often by HUs. The only category named more often by
NHUs than HUs was “for relaxation” (21.4% versus 12.7%).
With regard to the sources of information on CAM the
survey showed that for the HUs nonmedical practitioners
played a considerably greater role than treating physicians
(Figure 1). In the large majority of cases HUs received their
prescriptions from nonmedical practitioners (56% versus
29.4% of NHUs). Self-medication played a lesser role for
HUs than NHUs (13.8% versus 23.4%). The same holds for
the social environment (28.9% versus 42.3%) (Figure 2).
The timing of CAM use in the course of the illness
showed about the same distribution in both groups. In most
cases CAM was used at the same time as the conventional
treatment performed by the pediatric oncologist. 14% of the
users had used, CAM only after the end of the conventional
therapy.
4.3. Patterns of Communication. The percentage of families
who spoke with their doctors about using CAM with their
child was particularly high amongst the HUs. A total of
77.7% of the HUs spoke to a doctor about use of CAM
compared with about two thirds of the NHUs (65.2%).
With regard to the doctors’ responses (“recommended,”
“tooknote,”“advisedagainst,”“donotknow”)thereweresig-
niﬁcant diﬀerences between the hospital doctors addressed
by HUs and NHUs. 7.3% of the HU group reported that the4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Sources of information about CAM (n = 367 CAM-users; multiple answers possible). ∗Heilpraktiker: state registered, non-
physician health care provider of CAM in Germany, Austria and Switzerland.
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Figure 2: CAM-prescribers (n = 367 CAM-users; multiple answers possible).
hospital doctors approached by them had recommended use
compared with 17.3% of the NHU group (P = .02). 72.7%
of the hospital doctors of the HUs took note of the CAM
use without comment compared with 55.5% of the doctors
of NHUs while 20% of the hospital doctors of HUs advised
against CAM use compared with 27.3% of doctors of NHUs.
There was no identiﬁable diﬀerence between HUs and NHUs
with regard to the reactions of the pediatricians or general
practitioners addressed.
4.4. Hoped for and Experienced Eﬀect. There was no essential
diﬀerence between the two groups with regard to their basic
conviction about the eﬃcacy of CAM; before use 68% of
the HUs and 59.2% of the NHUs were “absolutely sure”
or “fairly sure” that CAM would have a positive impact on
their child’s illness. However, the percentage of “doubters”
was higher in the NHU group (31.8% versus 21.1%). In
the NHU group, the parents’ assessments of the actual
eﬀect of homeopathy on their child’s illness showed noEvidence-Based Complementary and Alternative Medicine 5
essential diﬀerences compared with their expectations (data
not shown).
When asked about side-eﬀects, 4.4% of all CAM users
reported one nonspeciﬁc side-eﬀect (n = 16 of 358 of
CAM users answering this question, multiple responses were
allowed). There were no signiﬁcant diﬀerences between HUs
and NHUs (data not shown).
The fundamentally positive attitude (hoped for and
experienced eﬀect) of all CAM users is reﬂected in the
willingness of the parents to recommend CAM use to
other parents in a similar situation: 89.4% of all CAM
users would do this (94% of HUs, 85.6% of NHUs). It is
not surprising that HUs would recommend homeopathy
most often whereas in the case of NHUs homeopathy
is only in 32nd place amongst the recommended CAM
therapies. Mistletoe therapy, on the other hand, is frequently
recommended in both groups (place 2 for HUs and place 1
for NHUs).
5. Discussion
These data are from the most extensive as well as the ﬁrst
population-based study on the prevalence of CAM use in
pediatric oncology. There have been no other studies to date
either on the use of homeopathy in pediatric oncology or
in comparison with users of other CAM therapies. In our
survey, population users of homeopathy were the largest
group (45.2%). In the results of non-European studies,
homeopathy only plays a marginal role if any: Israel 16.4%
[23], Canada 1.2% [12], and USA not mentioned [15]. Only
one recent study from Italy [24] and a small study from the
Netherlands [9] also found that homeopathy was the most
frequently mentioned CAM therapy amongst children with
cancer. This high rate of homeopathy use conﬁrms the fact
thathomeopathyinchildrenisusedmostoftenfortreatment
of chronic illnesses or of acute self-limiting illnesses [25–27].
An important factor which inﬂuences the likelihood of
CAM use in a child with cancer is previous experience of
CAM in the family before the child’s cancer. 37.3% of all
survey participants had already had experience of CAM, a
ﬁgure which is lower than that in the German population
as a whole [28, 29]. On the other hand, 76.5% of HUs
had previous experience of CAM, always of homeopathy.
In comparison with NHUs (27.4% previous experience of
homeopathy) this diﬀerence is statistically signiﬁcant and
was not previously known.
In HUs more than in NHUs the reasons given for the use
of CAM were related to reduction of concomitant symptoms
of the illness or of the conventional therapy. But general
treatment goals such as “to enhance the immune system”
or “for detoxiﬁcation” were also named disproportionately
often by HUs. There are no comparable data in the literature.
A large percentage of HUs (77.7%) had spoken with
a doctor (GP, pediatrician, pediatric oncologist) about the
use of homeopathic medicines. Surveys on the use of
homeopathy in general pediatrics have shown considerably
less willingness to talk to a doctor about the homeopathic
treatment [25]. But 65.2% of the NHUs in our survey
population also spoke to a doctor about their use of
CAM therapies. The reactions of the pediatric oncologists
approached diﬀered substantially between the two groups,
thoseapproachedbytheNHUsactivelyrecommendingCAM
use signiﬁcantly less often (7.3% versus 17.3%).
Although the HUs spoke strikingly often to the doc-
tors involved in their child’s treatment, these play only
a subordinate role when it comes to the prescribing of
the homeopathic medicines. Most prescriptions for home-
opathic medicines (which are usually available over-the-
counter) came from nonmedical practitioners. This is in
agreement with the results of other studies investigating the
use of homeopathy in pediatrics [24, 25, 30].
In contrast to an epidemiological study on the status of
homeopathy in children in Germany [31], our data show no
dependence of the use of homeopathy compared to NHUs
on higher social status. However, in the analysis of the total
study population (HUs + NHUs) a higher social status was
one of the statistically most striking factors inﬂuencing the
use of CAM in general.
In view of the fundamentally positive expectations of
the CAM users, the high percentage who would further
recommend CAM to parents in a comparable situation is not
surprising. However, here too there is a diﬀerence between
the two groups, 94% of the HUs stating that they would
further recommend CAM compared with 85.6% of the
NHUs. Our data also show that HUs continue homeopathic
treatment signiﬁcantly longer than patients using other
CAM therapies. A possible reason for the high degree of
satisfaction of HUs could be the fact that homeopaths devote
more time and attention to their patients. A homeopathic
interview can take as long as 1-2 hours. In a qualitative
comparative study of homeopaths and conventional doctors
it was found that the parents experienced the treatment by
a homeopath as more holistically oriented compared with
the symptom-based approach of a conventional doctor [32].
This probably also applies to the HUs in this survey, even
though the prescribers were for the most part nonmedical
practitioners. The data obtained in this survey do not
permit any conclusions regarding the eﬀectiveness of the
treatment, the occurrence of side-eﬀects, or interactions
with the homeopathic medicines. Furthermore, in a double-
blind clinical trial published by Paris et al., patients in both
groups (active treatment and placebo) were convinced of
the eﬀectiveness of homeopathy both before and after the
treatment [29]. Nevertheless, the analysis demonstrated the
homeopathic treatment to be as ineﬀective as the placebo.
On the one hand, trials of homeopathy trials, as of some
other treatments, are associated with high patient conviction
of eﬃcacy from the outset. This seems to be a persistent
problem and has to be taken into account methodologically.
On the other hand, assuming the therapy was eﬀective,
the subjective assessment by the parents displays that the
complementary homeopathic therapy was associated with a
perceived beneﬁt. Whether this had anything to do with an
actual therapeutic eﬀect or any other psychological eﬀects,
for example, “meaning response” [26] or placebo-eﬀect[32],
is not yet known as the methods used in this study do not
permit diﬀerentiation of these eﬀects.6 Evidence-Based Complementary and Alternative Medicine
6. Limitations
As a relatively high percentage of the responding families
used anthroposophic medicine (AM) in addition to the
homeopathy, the frequency of use of homeopathy in pedi-
atriconcologyinGermanymaybeoverreportedinthisstudy.
Lay people in particular often ﬁnd it diﬃcult to distinguish
between AM and homeopathy as both treatment systems use
potentized medicines. It is possible that some of the fami-
lies who were prescribed medicines by an anthroposophic
doctor incorrectly reported this as homeopathy. However,
it is unlikely that homeopathic medicines were incorrectly
reported as AM. Anthroposophic medicine is partly used as
an extension to conventional medicine and partly replaces
it [33]. The treatment and therapeutic possibilities oﬀered
by AM include specially produced medicines of mineral,
plant, and animal origin, various artistic therapies, rhythmic
massage [33], curative eurythmy [34], external treatments
(compresses, oils and ointments, baths), medical consul-
tations and counselling (partly psychotherapeutic), and
extendedanthroposophicnursingandcare.Thesetreatments
and therapies aim to stimulate and strengthen the patient’s
own healing forces; they are practiced by physicians, ther-
apists, and nurses. Physicians are trained in both AM and
conventional medicine and most are medical specialists. A
further limitation is that the questionnaire was only available
in German and that certain patient groups may therefore
have been indirectly excluded from the survey.
7. Conclusion
Homeopathy is the most frequently used complementary
therapy in pediatric oncology in Germany. Most HUs had
used homeopathy before the cancer and would further
recommend homeopathy to others in a similar situation.
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